Crafton aims to become a globally competitive mRNA company by leveraging innovative mRNA technologies that drive the emergence of new therapeutic modalities. Through agile management decisions and focused research development, we seek to continuously generate breakthrough technologies with the potential to shape the future of medicine.
Our mission is to realize innovative mRNA drug discovery and development through our proprietary platform technologies, and to deliver safer medicines to children who will shape the future, to patients suffering from intractable diseases, and to people around the world who can benefit from preventive therapies.

The company is focused on addressing key bottlenecks in mRNA medicine, including impurity-driven innate immune activation, manufacturing complexity, delivery limitations, and the need for improved therapeutic performance in high-value clinical applications.
By combining high-purity mRNA production through PureCap®, application-specific delivery strategies, and advanced RNA synthesis technologies, Crafton aims to enable safer, more scalable, and more clinically translatable mRNA medicines.